Michael Klichinsky is the co-founder and chief scientific officer of Carisma Therapeutics, which is developing macrophage-based cell therapies for cancer.

mR­NA’s next trick? Re­pro­gram­ming off-the-shelf cell ther­a­pies for can­cer and au­toim­mune dis­eases

A hand­ful of biotechs, in­clud­ing Mod­er­na, are bet­ting that sim­ple in­fu­sions with mR­NA could su­per­charge im­mune cells to fight can­cer and oth­er dis­eases in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.